About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Expert Opinion on Therapeutic Targets
›
Top Articles
Expert Opinion on Therapeutic Targets
Pharmacology
,
Biology
,
Biochemistry
,
Clinical Biochemistry
6.4
(top 2%)
Impact Factor
6.9
(top 2%)
extended IF
93
(top 4%)
H-Index
1.9K
authors
1.9K
papers
58.7K
citations
4.5K
citing journals
55.4K
citing authors
Most Cited Articles of Expert Opinion on Therapeutic Targets
Title
Year
Citations
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
2012
531
Targeting the EGFR signaling pathway in cancer therapy
2012
512
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
2012
472
Targeting selectins and selectin ligands in inflammation and cancer
2007
283
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
2007
278
The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy
2010
263
STAT proteins as novel targets for cancer drug discovery
2004
233
Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase
2012
222
Targeting the dopamine D2 receptor in schizophrenia
2006
219
Cathepsin B as a cancer target
2013
216
The role of dopamine in motivation for food in humans: implications for obesity
2002
196
The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction
2008
189
The 5-HT3 receptor as a therapeutic target
2007
185
From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer
2006
178
MERS-CoV spike protein: a key target for antivirals
2017
176
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
2011
175
Inhibiting the transcription factor HSF1 as an anticancer strategy
2009
174
Wnt signaling as a therapeutic target for bone diseases
2009
171
Tyrosine kinases as targets in cancer therapy - successes and failures
2003
171
Targeting the Bcl-2 family for cancer therapy
2013
168
Targeting the HGF/Met signaling pathway in cancer therapy
2012
162
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
2011
160
Overcoming drug resistance in pancreatic cancer
2011
157
Targeting the PI3K signaling pathway in cancer therapy
2012
156
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
2015
153
previous
2000
2001
2002
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.